Clinical Trial Update: Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating radiation therapy with paclitaxel and carboplatin with or without trastuzumab in esophageal and gastroesophageal junction adenocarcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Adenocarcinoma
• Esophageal Cancer
• Gastroesophageal Junction Adenocarcinoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2021-05-04